Bumpus Namandje

Director at RXRX

Sold, on record
$28k
Dollars the filings state
Form 4 sales
2
Latest Jun 18, 2026
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • RXRXRECURSION PHARMACEUTICALS, INC.Director

Sales by reason

2
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, every sale on record.

Sales chart range

Timeline

  1. 1 Form 144 notice RXRXNotice
    Jun 3, 2026 2026

    Filed to sell 4,386 shares ($16k)

    Bumpus Namandje, Director

    10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale RXRXRoutine
    Jun 3, 2026 same day

    Sold 4,386 shares at $3.54 ($16k)

    Bumpus Namandje, Director

    10b5-1 planSold 9.2% of holdings ($168k position)43,171 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 144 notice RXRXNotice
    Jun 18, 2026 +15 days

    Filed to sell 3,963 shares ($13k)

    Bumpus Namandje, Director

    10b5-1 planFiling

  4. 4 Form 4 sale RXRXRoutine
    Jun 18, 2026 same day

    Sold 3,963 shares at $3.18 ($13k)

    Bumpus Namandje, Director

    10b5-1 planSold 3% of holdings ($418k position)127,632 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Bumpus Namandje
Source
Jun 18, 2026Jun 22, 2026RXRXDirectorForm 4 sale3,963$13k3.0%RoutineSEC
Jun 18, 2026Jun 18, 2026RXRXDirectorForm 144 notice3,963$13kNoticeSEC
Jun 3, 2026Jun 4, 2026RXRXDirectorForm 4 sale4,386$16k9.2%RoutineSEC
Jun 3, 2026Jun 3, 2026RXRXDirectorForm 144 notice4,386$16kNoticeSEC